Yu-Shan Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yu-Shan Chang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Chyi-Her Lin
Department of Pediatrics, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan; School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung, Taiwan; Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
2 shared publications Yen-Ju Chen
Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng-Kung University, Tainan, Taiwan
2 shared publications- Yuh-Jyh Lin
Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
2 shared publications - Chi-Chang Shieh
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan City, Taiwan
1 shared publication - Chia-Liang Yen
Institute of Clinical Medicine, College of Medicine, National Cheng-Kung University Tainan, Taiwan
1 shared publication Chih-An Chen
Department of Pediatrics, National Cheng-Kung University Hospital, Tainan, Taiwan
1 shared publication
Latest Publications
- Open Access
- 23 June 2026
- Published by Elsevier in SSRN Electronic Journal
ER Stress-Induced Reductive Environment Destabilizes Adiponectin Oligomers: Implications for Redox-Based Therapies
Background: Adiponectin circulates in low (LMW), medium (MMW), and high molecular weight (HMW) oligomeric forms. The HMW form is most biologically active but is markedly reduced in obesity, contributing to metabolic dysfunction. The mechanisms driving adiponectin destabilization remain poorly understood.Methods: Adiponectin stability and oligomer distribution were evaluated in bariatric surgery patients and ob/ob mice using protease digestion assays. The impact of endoplasmic reticulum (ER) stress and redox homeostasis was investigated in vitro and ex vivo using pharmacological modulators. A retrospective cohort study via TriNetX compared metabolic outcomes in patients treated with TUDCA versus Silymarin.Results: Plasma adiponectin increased post-bariatric surgery despite unchanged adipose expression. Protease digestion revealed enhanced degradation in obesity, specifically affecting LMW oligomers. Thapsigargin-induced ER stress shifted distribution toward LMW forms and reduced stability. ER-targeted redox sensors demonstrated that ER stress promotes a reductive environment, impairing oligomerization. In vitro glutathione depletion rescued adiponectin stability by shifting redox balance toward oxidation. Ex vivo, chemical chaperones TUDCA and PBA improved stability, though redox modulation with DEM had no effect. Real-world TriNetX data showed TUDCA treatment produced greater HbA1c and LDL-C reductions compared to Silymarin, a well-known adjuvant therapy for metabolic syndrome.Conclusion: Obesity-related ER stress induces a reductive ER environment that destabilizes adiponectin, shifting it toward LMW forms. Targeting ER stress and redox homeostasis represents a promising therapeutic strategy for restoring adiponectin function in metabolic disease.
- 23 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessER Stress-Induced Reductive Environment Destabilizes Adiponectin Oligomers: Implications for Redox-Based Therapies
Background: Adiponectin circulates in low (LMW), medium (MMW), and high molecular weight (HMW) oligomeric forms. The HMW form is most biologically active but is markedly reduced in obesity, contributing to metabolic dysfunction. The mechanisms driving adiponectin destabilization remain poorly understood.Methods: Adiponectin stability and oligomer distribution were evaluated in bariatric surgery patients and ob/ob mice using protease digestion assays. The impact of endoplasmic reticulum (ER) stress and redox homeostasis was investigated in vitro and ex vivo using pharmacological modulators. A retrospective cohort study via TriNetX compared metabolic outcomes in patients treated with TUDCA versus Silymarin.Results: Plasma adiponectin increased post-bariatric surgery despite unchanged adipose expression. Protease digestion revealed enhanced degradation in obesity, specifically affecting LMW oligomers. Thapsigargin-induced ER stress shifted distribution toward LMW forms and reduced stability. ER-targeted redox sensors demonstrated that ER stress promotes a reductive environment, impairing oligomerization. In vitro glutathione depletion rescued adiponectin stability by shifting redox balance toward oxidation. Ex vivo, chemical chaperones TUDCA and PBA improved stability, though redox modulation with DEM had no effect. Real-world TriNetX data showed TUDCA treatment produced greater HbA1c and LDL-C reductions compared to Silymarin, a well-known adjuvant therapy for metabolic syndrome.Conclusion: Obesity-related ER stress induces a reductive ER environment that destabilizes adiponectin, shifting it toward LMW forms. Targeting ER stress and redox homeostasis represents a promising therapeutic strategy for restoring adiponectin function in metabolic disease.
- 13 December 2025
- Published by Elsevier in Toxicology
- Vol. 520, 154373
Prenatal diesel exhaust exposure enhances neonatal hyperoxia-induced kidney injury via oxidative stress and lipid disruption
- 13 December 2025
- Published by Elsevier in Toxicology
- Vol. 520, 154373
Prenatal diesel exhaust exposure enhances neonatal hyperoxia-induced kidney injury via oxidative stress and lipid disruption
- Open Access
- 17 November 2025
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 67 (3) , 305-309
Association of early respiratory support with mortality and bronchopulmonary dysplasia in very-low-birth-weight preterm infants
- 17 November 2025
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 67 (3) , 305-309
Open AccessAssociation of early respiratory support with mortality and bronchopulmonary dysplasia in very-low-birth-weight preterm infants
- Open Access
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1) , 8285898
Lipopolysaccharide Sensitizes Steroid‐Induced Brain Injury in Neonatal Rat Pups
Background: Infection is a pathogenetic factor for bronchopulmonary dysplasia (BPD), and corticosteroids are often used for its prevention or treatment. However, few studies have examined their combined effects on brain injury in the context of infection. Methods: Rat pups received lipopolysaccharide (LPS) on postnatal Day 1 (P1), followed by tapering doses of dexamethasone (Dex) or hydrocortisone (HC) from P2 to P4. We measured body and brain weights, TUNEL‐positive cell counts, synaptic protein levels, and mRNA expression of glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) in six brain regions at P5. Results: The LPS‐HC and LPS‐Dex groups showed more TUNEL‐positive cells in the hippocampus, cerebellum, and brain stem compared to LPS‐naïve controls. Oligodendrocyte precursor cells were the predominant TUNEL‐positive cells in the hippocampus and brain stem. Additionally, the LPS‐Dex or LPS‐HC group showed significantly reduced levels of postsynaptic density protein 95 (PSD95), a postsynaptic protein, in these regions, while treatment with Dex or HC alone did not impact PSD95 expression. GR mRNA was significantly reduced in cortex, striatum, hippocampus, and cerebellum in LPS‐HC group, with MR mRNA reduction limited primarily to the striatum. Conclusions: LPS sensitized the immature brain to Dex or HC‐related cell death to possible apoptosis and augmented the LPS‐induced disruption of synaptic integrity in certain brain regions, potentially via altered GR and MR expression that may modulate corticosteroid receptor signaling.
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1) , 8285898
Open AccessLipopolysaccharide Sensitizes Steroid‐Induced Brain Injury in Neonatal Rat Pups
Background: Infection is a pathogenetic factor for bronchopulmonary dysplasia (BPD), and corticosteroids are often used for its prevention or treatment. However, few studies have examined their combined effects on brain injury in the context of infection. Methods: Rat pups received lipopolysaccharide (LPS) on postnatal Day 1 (P1), followed by tapering doses of dexamethasone (Dex) or hydrocortisone (HC) from P2 to P4. We measured body and brain weights, TUNEL‐positive cell counts, synaptic protein levels, and mRNA expression of glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) in six brain regions at P5. Results: The LPS‐HC and LPS‐Dex groups showed more TUNEL‐positive cells in the hippocampus, cerebellum, and brain stem compared to LPS‐naïve controls. Oligodendrocyte precursor cells were the predominant TUNEL‐positive cells in the hippocampus and brain stem. Additionally, the LPS‐Dex or LPS‐HC group showed significantly reduced levels of postsynaptic density protein 95 (PSD95), a postsynaptic protein, in these regions, while treatment with Dex or HC alone did not impact PSD95 expression. GR mRNA was significantly reduced in cortex, striatum, hippocampus, and cerebellum in LPS‐HC group, with MR mRNA reduction limited primarily to the striatum. Conclusions: LPS sensitized the immature brain to Dex or HC‐related cell death to possible apoptosis and augmented the LPS‐induced disruption of synaptic integrity in certain brain regions, potentially via altered GR and MR expression that may modulate corticosteroid receptor signaling.
- Open Access
- 27 February 2023
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 56 (4) , 871-874
Postnatal corticosteroid treatment as a risk factor for false positivity in severe combined immunodeficiency newborn screening
- 27 February 2023
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 56 (4) , 871-874
Open AccessPostnatal corticosteroid treatment as a risk factor for false positivity in severe combined immunodeficiency newborn screening
- Open Access
- 10 November 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 122 (6) , 493-504
Preterm birth and weight-for-gestational age for risks of autism spectrum disorder and intellectual disability: A nationwide population-based cohort study
- 10 November 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 122 (6) , 493-504
Open AccessPreterm birth and weight-for-gestational age for risks of autism spectrum disorder and intellectual disability: A nationwide population-based cohort study